Baird et al., 1988 - Google Patents
Structural mapping of membrane-associated proteins: a case study of the IgE-receptor complexBaird et al., 1988
- Document ID
- 16179662392578906935
- Author
- Baird B
- Holowka D
- Publication year
- Publication venue
- Spectroscopic Membrane Probes
External Links
- 102000018697 Membrane Proteins 0 title abstract description 4
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/5432—Liposomes or microcapsules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DÜzgÜneş et al. | Fluorescence assays for membrane fusion | |
Simmonds et al. | Annular and non-annular binding sites on the (Ca2++ Mg2+)-ATPase | |
Ruetz et al. | Phosphatidylcholine translocase: a physiological role for the mdr2 gene | |
Kaiser et al. | Determination of the depth of BODIPY probes in model membranes by parallax analysis of fluorescence quenching | |
Hoekstra et al. | Characterization of the fusogenic properties of Sendai virus: kinetics of fusion with erythrocyte membranes | |
Brown et al. | Definition of distinct compartments in polarized Madin–Darby canine kidney (MDCK) cells for membrane‐volume sorting, polarized sorting and apical recycling | |
Hannan et al. | Correctly sorted molecules of a GPI-anchored protein are clustered and immobile when they arrive at the apical surface of MDCK cells. | |
Loew | Spectroscopic membrane probes | |
Sarkar et al. | Initial stages of influenza hemagglutinin-induced cell fusion monitored simultaneously by two fluorescent events: cytoplasmic continuity and lipid mixing. | |
Uster et al. | pH-dependent fusion of liposomes using titratable polycations | |
Matos et al. | Quantitative assessment of peptide–lipid interactions.: Ubiquitous fluorescence methodologies | |
Churchward et al. | Cholesterol, regulated exocytosis and the physiological fusion machine | |
Hofmann et al. | Self-interaction of a SNARE transmembrane domain promotes the hemifusion-to-fusion transition | |
Pécheur et al. | Membrane anchorage brings about fusogenic properties in a short synthetic peptide | |
Carneiro et al. | Probing the interaction between vesicular stomatitis virus and phosphatidylserine | |
Orr et al. | Yeast vacuolar HOPS, regulated by its kinase, exploits affinities for acidic lipids and Rab: GTP for membrane binding and to catalyze tethering and fusion | |
Loura et al. | Membrane probe distribution heterogeneity: a resonance energy transfer study | |
Rosconi et al. | Analyzing topography of membrane-inserted diphtheria toxin T domain using BODIPY-streptavidin: At low pH, helices 8 and 9 form a transmembrane hairpin but helices 5− 7 form stable nonclassical inserted segments on the cis side of the bilayer | |
Smith et al. | Dynamic organization of myristoylated src in the live cell plasma membrane | |
Matos et al. | Interaction of peptides with biomembranes assessed by potential‐sensitive fluorescent probes | |
Owen | A membrane-bound fluorescent probe to detect phospholipid vesicle-cell fusion | |
Baird et al. | Structural mapping of membrane-associated proteins: a case study of the IgE-receptor complex | |
Hu et al. | In situ quantification of lipids in live cells by using lipid-binding domain-based biosensors | |
Caster et al. | A role for cargo in Arf-dependent adaptor recruitment | |
Korte et al. | Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity |